Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1477 of 5804
-
New combo tackles relapsed blood cancers after transplant
Disease control OngoingStudy to assess venetoclax + azacitidine and donor lymphocyte infusion (DLI) in patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) in relapse after allohematopoietic stem cell transplantation (AHSCT).
Phase: PHASE1, PHASE2 • Sponsor: Groupe Francophone des Myelodysplasies • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New combo therapy aims to slow lung scarring in hypersensitivity pneumonitis
Disease control OngoingTo our knowledge, there is no randomized controlled trial assessing the efficacy of mycophenolate mofetil (MMF) in the treatment of HP. We aim to perform a randomized study to assess the efficacy and safety of a regimen consisting of MMF and prednisolone against a regimen consist…
Phase: PHASE4 • Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New study pits heat, cold, and knife against lung cancer
Disease control OngoingThis clinical study is evaluating different treatment options for patients with malignant lung tumors, including both primary lung cancer and tumors that have spread to the lungs from other parts of the body. The goal is to compare the safety, effectiveness, and quality-of-life i…
Phase: NA • Sponsor: Aurimas Macionis • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Can a common blood pressure pill prevent heart attacks after kidney failure in the ICU?
Disease control OngoingThe patients discharged from intensive care units (ICU) have a high incidence of cardiovascular events and mortality rate during the year following ICU discharge. Among patients admitted to the ICU, patients with acute kidney injury (AKI) display high risk of such events. The inv…
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 26, 2026 14:26 UTC
-
Eye drops could replace needles for wet AMD?
Disease control CompletedThe goal of this clinical trial is to compare the safety and effect on visual acuity of three different doses of SYL1801 eye drops.
Phase: PHASE2 • Sponsor: Sylentis, S.A. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Experimental vaccine aims to stop liver cancer from returning
Disease control OngoingThe trial is designed as a single-arm, open-label, phase I study investigating an off-the-shelf, multi-peptide-base HCC vaccine plus Montanide, combined with Durvalumab in patients with very early, early and intermediate stage of HCC. The investigational agents will be applied wi…
Phase: PHASE1 • Sponsor: National Cancer Institute, Naples • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New Triple-Action antibody targets Hard-to-Treat blood cancers
Disease control Recruiting nowThe primary purpose of this study is to identify the recommended phase 2 dose (RP2D\[s\]) and schedule(s) to be safe for JNJ-79635322 in Part 1 (dose escalation), and to characterize the safety and tolerability of JNJ-79635322 at the RP2D(s) selected and in disease subgroups in P…
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Blood marker may reveal which over-80s can survive ICU without losing independence
Knowledge-focused OngoingFor the last twenty years, the proportion of patients aged 80 years and more, hospitalized in intensive care (ICU) has been increasing. The question of the admission of an elderly patient in intensive care raises many medico-socio-economic questions. The general objective of geri…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
New drug trial for MET-Positive lung cancer halted early
Disease control TerminatedCancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell lung cancer (NSCLC) is a solid tumor, a disease in which cancer cells form in the tissues of the lung. The purpose of this study is to determine how telisotuzumab vedoti…
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New hope for advanced lung cancer: drug combo trial launches
Disease control Recruiting nowThis phase I trial studies the side effects and best dose of PBF-1129 in combination with nivolumab in treating patients with non-small cell lung cancer that has come back (recurrent) or spread to other places in the body (metastatic). Immunotherapy with monoclonal antibodies, su…
Phase: PHASE1 • Sponsor: Dwight Owen • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New hope for cancer patients: combating sleepless nights with light and therapy
Symptom relief Recruiting nowTo learn if Cognitive Behavior Therapy (called CBT), combined with either Bright Light Therapy (called BLT), methylphenidate, and/or melatonin, can help improve sleep and other related symptoms such as fatigue, anxiety, and depression in cancer patients. This is an investigationa…
Phase: PHASE2, PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
New pill shows promise for ulcerative colitis sufferers
Disease control OngoingThis is a Phase 2b randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of three active dose regimens of MORF-057 in adult patients with moderately to severely active Ulcerative Colitis (UC).
Phase: PHASE2 • Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Could a poop pill curb alcohol cravings in liver disease patients?
Disease control Recruiting nowThe purpose of this research study is to test the safety, tolerability, and effectiveness of the capsules that contain bacteria from healthy individuals when used to treat alcohol craving and drinking.
Phase: PHASE1, PHASE2 • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Could talk therapy help teens with diabetes? a new pilot study explores DBT for mind and body
Disease control CompletedIn partnership with youth, parents, and community members the investigators have co-developed a program of research designed to address the substantial health disparities faced by First Nations children and families, and the calls to action from the Truth and Reconciliation Repor…
Phase: NA • Sponsor: Dr. Brandy Wicklow • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Chemotherapy sprayed directly into the abdomen: a new attack on stubborn cancers
Disease control OngoingThe PIPAC NAL-IRI study is designed to examine the maximal tolerated dose of nanoliposomal irinotecan (Nal-IRI, Onivyde) administered with repeated pressurized intraperitoneal aerosol chemotherapy (PIPAC), in a monocentric, phase I trial.
Phase: PHASE1 • Sponsor: University Hospital, Ghent • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could a gentle brain zap boost memory in Alzheimer's and lewy body dementia?
Symptom relief Recruiting nowDouble blinded, sham-controlled, randomized trial on repeated transcranial alternating current brain stimulation (tACS) in neurodegenerative diseases. The investigators will evaluate whether a 4-times daily repeated stimulation with gamma tACS on the posterior parietal cortex can…
Phase: NA • Sponsor: Kuopio University Hospital • Aim: Symptom relief
Last updated Jun 26, 2026 12:44 UTC
-
Experimental drug duo takes on tough leukemia
Disease control Recruiting nowThis study aims to learn about the safety, tolerability, and different dose levels' safety profiles of Venetoclax and Bomedemstat (VenBom) combination therapy in participants with relapsed or refractory acute myeloid leukemia.
Phase: PHASE1 • Sponsor: Terrence J Bradley, MD • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
AI listens for early dementia: a 3-Minute voice test shows promise
Diagnosis CompletedDementia, especially dementia caused by Alzheimer's disease, is considered one of the most severe health problems of our time. It is currently known that the disease begins many years before clinical symptoms appear. The sooner the patient is diagnosed, the sooner the patient wil…
Sponsor: Accexible • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
New PET tracer aims to spot Alzheimer's plaques safely
Diagnosis OngoingThe purpose of this research study is to determine the safety of a radiotracer 18F-Fluselenamyl using positron emission tomography (PET) imaging. The investigators will first complete whole-body PET dosimetry studies in healthy adult normal volunteers to calculate the actual rad…
Sponsor: Washington University School of Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 13:05 UTC
-
Heart health hope: new program targets high blood pressure in orange county families
Prevention OngoingThe Skills-Based Educational strategies for Reduction of Vascular Events in Orange County, CA (SERVE OC) study aims to evaluate the efficacy of a culturally tailored, skills-based, cardiovascular health (CVH) intervention amongst a cohort of Latinx and Vietnamese families in Sant…
Phase: NA • Sponsor: University of California, Irvine • Aim: Prevention
Last updated Jun 27, 2026 14:01 UTC